findmyKOL
Clinical trialNCT00679354CompletedPhase 2Interventional

Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard Therapy

SponsorNational Cancer Institute (NCI)Enrollment30Childhood High-grade Cerebellar AstrocytomaChildhood High-grade Cerebral AstrocytomaRecurrent Childhood Anaplastic AstrocytomaRecurrent Childhood Anaplastic OligoastrocytomaRecurrent Childhood Anaplastic OligodendrogliomaRecurrent Childhood Brain Tumor+4 more conditions
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Cancercare Manitoba

    Winnipeg, Manitoba, Canada

United States
  • Kaiser Permanente-Oakland

    Oakland, California, United States

  • University of California San Francisco Medical Center-Parnassus

    San Francisco, California, United States

  • Lombardi Comprehensive Cancer Center at Georgetown University

    Washington D.C., District of Columbia, United States

  • Lurie Children'S Hospital-Chicago

    Chicago, Illinois, United States

  • Massachusetts General Hospital Cancer Center

    Boston, Massachusetts, United States

  • Wayne State University/karmanos Cancer Institute

    Detroit, Michigan, United States

  • Newark Beth Israel Medical Center

    Newark, New Jersey, United States

  • New York University Langone Medical Center

    New York, New York, United States

  • Montefiore Medical Center

    The Bronx, New York, United States

  • Wake Forest University Health Sciences

    Winston-Salem, North Carolina, United States

  • Children'S Hospital Medical Center of Akron

    Akron, Ohio, United States

  • Nationwide Children'S Hospital

    Columbus, Ohio, United States

  • Oregon Health and Science University

    Portland, Oregon, United States

  • Children'S Hospital of Philadelphia

    Philadelphia, Pennsylvania, United States

  • Palmetto Health Richland

    Columbia, South Carolina, United States

  • T C Thompson Children'S Hospital

    Chattanooga, Tennessee, United States

  • St. Jude Children'S Research Hospital

    Memphis, Tennessee, United States

  • Seattle Children'S Hospital

    Seattle, Washington, United States

  • Midwest Children'S Cancer Center

    Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Jun 2008
Primary completion
31 Oct 2010
Completion
31 Jul 2011
Last update posted
1 Aug 2018
Registered enrollment
30
Registry id
NCT00679354

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.